Business · 27/11/2020
FDA Extends Comment Period for Antimicrobial Drug Ranking Proposal
The US Food and Drug Administration (FDA) is extending the comment period for a proposed approach to ranking antimicrobial drugs according to their importance in human medicine, in response to requests from interested parties.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →